BIG 1-98 : a randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571698600845166208
  • NII Article ID
    10025373327
  • Data Source
    • CiNii Articles

Report a problem

Back to top